EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION

被引：0
|
作者：
Fujii, Mitsuhiro [1 ]
Iwakami, Shin-Ichiro [1 ]
Ihara, Hiroaki [1 ]
Hara, Munechika [1 ]
Iwakami, Naoko [1 ]
Ishiwata, Toshiji [1 ]
Takahashi, Kazuhisa [2 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Hao Zeng
    Yuanyuan Zhang
    Sihan Tan
    Qin Huang
    Xin Pu
    Panwen Tian
    Yalun Li
    BMC Pulmonary Medicine, 24
  • [2] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Zeng, Hao
    Zhang, Yuanyuan
    Tan, Sihan
    Huang, Qin
    Pu, Xin
    Tian, Panwen
    Li, Yalun
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [3] The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
    Nagamine, Hiroaki
    Sawa, Kenji
    Kaneda, Hiroyasu
    Ogawa, Koichi
    Nakahama, Kenji
    Matsumoto, Yoshiya
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2022, 33 : S523 - S523
  • [4] THE EFFECT OF CARBOPLATIN PACLITAXEL AND BEVACIZUMAB FOR ADVANCED NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Kazuyori, Taisuke
    Tamura, Nobumasa
    Sasaki, Ryoko
    Hirano, Yuuta
    Tone, Kazuya
    Shinohara, Wakako
    Kojima, Akira
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2017, 22 : 116 - 116
  • [5] The efficacy of osimertinib in patients with EGFR-positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S510 - S511
  • [6] Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
    Song, Xinyu
    Chen, Dawei
    Guo, Jun
    Kong, Li
    Wang, Haiyong
    Wang, Zhehai
    ONCOTARGETS AND THERAPY, 2018, 11 : 8421 - 8426
  • [7] Predictive model for sarcopenia in patients with non-small cell lung cancer and malignant pleural effusion
    Gao, Hengxing
    Zou, Xuexue
    Fan, Meng
    Chen, Mingwei
    BMC CANCER, 2025, 25 (01)
  • [8] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kitamura, Kazuhiro
    Kubota, Kaoru
    Ando, Masahiro
    Takahashi, Satoshi
    Nishijima, Nobuhiko
    Sugano, Teppei
    Toyokawa, Masaru
    Miwa, Koji
    Kosaihira, Seiji
    Noro, Rintaro
    Minegishi, Yuji
    Seike, Masahiro
    Yoshimura, Akinobu
    Gemma, Akihiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 457 - 461
  • [9] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kazuhiro Kitamura
    Kaoru Kubota
    Masahiro Ando
    Satoshi Takahashi
    Nobuhiko Nishijima
    Teppei Sugano
    Masaru Toyokawa
    Koji Miwa
    Seiji Kosaihira
    Rintaro Noro
    Yuji Minegishi
    Masahiro Seike
    Akinobu Yoshimura
    Akihiko Gemma
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 457 - 461
  • [10] Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    THORACIC CANCER, 2024, 15 (05) : 402 - 409
12345